Back
Stride, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
47
LRN
Stride, Inc.
Last Price:
$66.05
Seasonality Move:
11.5%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Sell
47
Stride, Inc. (LRN)
is a Sell
Is Stride, Inc. a Buy, Sell or Hold?
-
The current Stride, Inc. [LRN] share price is $66.08. The Score for LRN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRN Stock Price Chart
What is Stride, Inc.'s stock price today?
-
The Stride, Inc. share price today is $66.08Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRN is experiencing slight selling pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.59The current trend is moderately bearish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
LRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.55 | Sell |
| Relative Strength Index (14 RSI): | 39.45 | Sell |
| Chaikin Money Flow: | -1153951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.15 - 65.33) | Buy |
| Bollinger Bands (100): | (77.07 - 161.47) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -1420728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 47.99) | Sell |
| Bollinger Bands (100): | (29.17 - 43.09) | Buy |
LRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.8 | Buy |
| 20-day SMA: | 63.53 | Buy |
| 50-day SMA: | 86.93 | Sell |
| 200-day SMA: | 128.96 | Sell |
| 8-day EMA: | 64.97 | Buy |
| 20-day EMA: | 66.44 | Sell |
| 50-day EMA: | 83.75 | Sell |
| 200-day EMA: | 114.49 | Sell |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Sell |
| 20-day SMA: | 45.09 | Sell |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 27.66 | Buy |
| 8-day EMA: | 42.28 | Sell |
| 20-day EMA: | 42.74 | Sell |
| 50-day EMA: | 39.8 | Buy |
| 200-day EMA: | 30.28 | Buy |
Stride, Inc. Earnings Growth & LRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.95 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Stride, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||